Intercept Pharmaceuticals Inc (ICPT)

65.07 -2.63  -3.88% NASDAQ Mar 27, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/08/2020 08:30 EDT Misc Intercept Pharmaceuticals Inc First Quarter Earnings Conference Call in 2020
05/08/2020 Earnings Intercept Pharmaceuticals Inc First Quarter Earnings in 2020 Release
02/25/2020 08:30 EST Misc Intercept Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/25/2020 Earnings Intercept Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
02/25/2020 Misc Intercept Pharmaceuticals Inc Annual Report for 2019
11/05/2019 08:30 EST Misc Intercept Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings Intercept Pharmaceuticals Inc Third Quarter Earnings for 2019 Release
08/07/2019 08:30 EDT Misc Intercept Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Intercept Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
06/20/2019 10:00 EDT Misc Intercept Pharmaceuticals Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.interceptpharma.com
  • Investor Relations URL: http://ir.interceptpharma.com/index.cfm
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: May. 08, 2020
  • Last Earnings Release: Feb. 25, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

Top Fund Holders

Symbol Name Weighting
CIG4924 CI Global Health Sciences Corp Cl Y 7.22%
VLLIX Value Line Larger Companies Focus Instl 3.17%
BFONX Biondo Focus Investor 2.90%
SBIO ALPS Medical Breakthroughs ETF 2.56%
VLIIX Value Line Capital Appreciation Instl 2.48%
HRSOX Harbor Small Cap Growth Opps Admin 1.25%
FIJYX Fidelity Advisor® Biotechnology Z 1.03%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.85%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.